Challenges in the clinical development of non-D2 compounds for schizophrenia
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2147342
Abstract: Abstract Schizophrenia is a chronic, heterogeneous, severe psychiatric disorder characterized by a spectrum of symptomology and is associated with substantial morbidity and mortality. For the last 70 years, available treatments have shared blockade of dopamine D2… read more here.
Keywords: challenges clinical; development; non compounds; clinical development ... See more keywords